Long-Acting Nifedipine for Hypertensive Patients in the Middle East and Morocco: Observations on Efficacy and Tolerability of Monotherapy or Combination Therapy.
Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy.
Integr Blood Press Control. 2013; 6: 49-57
Ghoneim RA, Omar AK, Sebastian V, Kassab R, Akijian G, Hafiz… Continue reading
Rapid Countermeasure Discovery Against Francisella Tularensis Based on a Metabolic Network Reconstruction.
Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction.
PLoS One. 2013; 8(5): e63369
Chaudhury S, Abdulhameed MD, Singh N, Tawa GJ, D’haeseleer PM, Zemla AT, Navid A, Zhou CE, Franklin MC, Cheung J, Rudolph MJ,… Continue reading
High-Throughput Screening for GPR119 Modulators Identifies a Novel Compound With Anti-Diabetic Efficacy in Db/db Mice.
High-Throughput Screening for GPR119 Modulators Identifies a Novel Compound with Anti-Diabetic Efficacy in db/db Mice.
PLoS One. 2013; 8(5): e63861
Zhang M, Feng Y, Wang J, Zhao J, Li T, He M, Yang D, Nosjean O, Boutin J, Renard… Continue reading
Tumor Burden Talks in Cancer Treatment With PEGylated Liposomal Drugs.
Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs.
PLoS One. 2013; 8(5): e63078
Lin YY, Kao HW, Li JJ, Hwang JJ, Tseng YL, Lin WJ, Lin MH, Ting G, Wang HE
PEGylated liposomes are important drug carriers that can passively target tumor by enhanced permeability and retention (EPR) effect in neoplasm lesions. This study demonstrated that tumor burden determines the tumor uptake, and also the tumor response, in cancer treatment with PEGylated liposomal drugs in a C26/tk-luc colon carcinoma-bearing mouse model.Empty PEGylated liposomes (NanoX) and those encapsulated with VNB (NanoVNB) were labeled with In-111 to obtain InNanoX and InVNBL in high labeling yield and radiochemical purity (all >90%). BALB/c mice bearing either small… Continue reading
Comparison of Responses of Human Melanoma Cell Lines to MEK and BRAF Inhibitors.
Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors.
Front Genet. 2013; 4: 66
Stones CJ, Kim JE, Joseph WR, Leung E, Marshall ES, Finlay GJ, Shelling AN, Baguley BC
The NRAS and BRAF genes… Continue reading
Retraction Notice to “In Situ-Forming Hydrogels for Sustained Ophthalmic Drug Delivery.” [COREL 122/2, 119–134].
Retraction notice to “In situ-forming hydrogels for sustained ophthalmic drug delivery.” [COREL 122/2, 119–134].
J Control Release. 2013 Apr 28; 167(2): 219
Nanjawade BK, Manvi FV, Manjappa AS
Sensitization of Staphylococcus aureus to Methicillin and… Continue reading
In Vivo Anticancer Activity of Vanillin Semicarbazone.
In vivo anticancer activity of vanillin semicarbazone.
Asian Pac J Trop Biomed. 2012 Jun; 2(6): 438-42
Ali SM, Azad MA, Jesmin M, Ahsan S, Rahman MM, Khanam JA, Islam MN, Shahriar SM
To evaluate the anticancer activity of vanillin… Continue reading
Anti-Dermatophytic Activity of Marine Sponge, Sigmadocia Carnosa (Dendy) on Clinically Isolated Fungi.
Anti-dermatophytic activity of marine sponge, Sigmadocia carnosa (Dendy) on clinically isolated fungi.
Asian Pac J Trop Biomed. 2012 Aug; 2(8): 635-9
Dhayanithi N, Kumar TA, Kalaiselvam M, Balasubramanian T, Sivakumar N
To screen the anti-fungal effects and find out… Continue reading
Amphetamine, Past and Present – a Pharmacological and Clinical Perspective.
Amphetamine, past and present – a pharmacological and clinical perspective.
J Psychopharmacol. 2013 Mar 28;
Heal DJ, Smith SL, Gosden J, Nutt DJ
Amphetamine was discovered over 100 years ago. Since then, it has transformed from a drug that… Continue reading